|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders.
|
21942426 |
2011 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.
|
20434300 |
2010 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Essential thrombocythemia: past and present.
|
19636672 |
2009 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden.
|
19154659 |
2009 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
[Primary thrombocythemia: diagnosis and therapy].
|
16896569 |
2006 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Molecular basis of the diagnosis and treatment of polycythemia vera and essential thrombocythemia.
|
16484586 |
2006 |
|
| Entrez Id: |
5155 |
| Gene Symbol: |
PDGFB |
PDGFB
|
0.300 |
Biomarker
|
disease |
CTD_human |
PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.
|
15682418 |
2005 |
|
| Entrez Id: |
5154 |
| Gene Symbol: |
PDGFA |
PDGFA
|
0.300 |
Biomarker
|
disease |
CTD_human |
PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.
|
15682418 |
2005 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
A gain-of-function mutation of JAK2 in myeloproliferative disorders.
|
15858187 |
2005 |
|
| Entrez Id: |
2247 |
| Gene Symbol: |
FGF2 |
FGF2
|
0.300 |
Biomarker
|
disease |
CTD_human |
PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.
|
15682418 |
2005 |
|
| Entrez Id: |
3717 |
| Gene Symbol: |
JAK2 |
JAK2
|
0.300 |
Biomarker
|
disease |
CTD_human |
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.
|
15781101 |
2005 |
|
| Entrez Id: |
7040 |
| Gene Symbol: |
TGFB1 |
TGFB1
|
0.300 |
Biomarker
|
disease |
CTD_human |
PDGF-A, PDGF-B, TGFbeta, and bFGF mRNA levels in patients with essential thrombocythemia treated with anagrelide.
|
15682418 |
2005 |
|
| Entrez Id: |
3440 |
| Gene Symbol: |
IFNA2 |
IFNA2
|
0.300 |
Therapeutic
|
disease |
CTD_human |
[Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
|
12924084 |
2003 |
|
| Entrez Id: |
7066 |
| Gene Symbol: |
THPO |
THPO
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
811 |
| Gene Symbol: |
CALR |
CALR
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
|
| Entrez Id: |
10019 |
| Gene Symbol: |
SH2B3 |
SH2B3
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|